138 results on '"Desnuelle, Claude"'
Search Results
2. Could the motor unit number index be an early prognostic biomarker for amyotrophic lateral sclerosis?
3. Memory B Cells Predict Relapse in Rituximab-Treated Myasthenia Gravis
4. Categorization of the amyotrophic lateral sclerosis population via the clinical determinant of post‐onset ΔFS for study design and medical practice.
5. Nutrition parentérale et sclérose latérale amyotrophique (SLA)
6. Brain computer interface with the P300 speller: Usability for disabled people with amyotrophic lateral sclerosis
7. Unusual association of amyotrophic lateral sclerosis and myasthenia gravis: A dysregulation of the adaptive immune system?
8. The European LEMS Registry: Baseline Demographics and Treatment Approaches
9. A novel CRYAB mutation resulting in multisystemic disease
10. Testing the validity of a set of diagnostic criteria for sensory neuronopathies: a francophone collaborative study
11. Clinical trials in pediatric ALS: a TRICALS feasibility study.
12. Coenzyme Q 10 is frequently reduced in muscle of patients with mitochondrial myopathy
13. Soins palliatifs dans les maladies neuromusculaires de l’enfant. Expérience d’une coopération entre une équipe de neuropédiatrie et une équipe ressource douleur et soins palliatifs pédiatriques
14. Neuromuscular Electrical Stimulation Training: A Safe and Effective Treatment for Facioscapulohumeral Muscular Dystrophy Patients
15. Correlation between low FAT1 expression and early affected muscle in facioscapulohumeral muscular dystrophy
16. The inward rectifier potassium channel Kir2.1 is required for osteoblastogenesis
17. Abnormalities of cerebral arteries are frequent in patients with late-onset Pompe disease
18. Do patients having a decrease in SNAP amplitude during the course of MMN present with a different condition?
19. A phase II−III trial of olesoxime in subjects with amyotrophic lateral sclerosis
20. DUX4 and DUX4 downstream target genes are expressed in fetal FSHD muscles
21. Use of the Faces Pain Scale by left and right hemispheric stroke patients
22. Development of a French Isometric Strength Normative Database for Adults Using Quantitative Muscle Testing
23. Increased levels of adenine nucleotide translocator 1 protein and response to oxidative stress are early events in facioscapulohumeral muscular dystrophy muscle
24. Dysregulation of 4q35- and muscle-specific genes in fetuses with a short D4Z4 array linked to facio-scapulo-humeral dystrophy
25. Can malondialdehyde be used as a biological marker of progression in neurodegenerative disease?
26. Patients with a phenotype consistent with facioscapulohumeral muscular dystrophy display genetic and epigenetic heterogeneity
27. Peut-on envisager une thérapie cellulaire autologue de la dystrophie musculaire facio-scapulo-humérale ?
28. A functionally dominant mitochondrial DNA mutation
29. Null Mutations Causing Depletion of the Type 1 Ryanodine Receptor (RYR1) Are Commonly Associated With Recessive Structural Congenital Myopathies With Cores
30. Familial clustering of primary lateral sclerosis and amyotrophic lateral sclerosis: Supplementary evidence for a continuum.
31. Muscle Glycogenosis and Mitochondrial Hepatopathy in an Infant With Mutations in Both the Myophosphorylase and Deoxyguanosine Kinase Genes
32. Évolution du concept de maladie mitochondriale
33. Effect of familial clustering in the genetic screening of 235 French ALS families.
34. The French national protocol for Kennedy's disease (SBMA): consensus diagnostic and management recommendations.
35. Phenotypic and genotypic studies of ALS cases in ALS-SMA families.
36. Safety of Intravenous Immunoglobulin (Tegeline®), Administered at Home in Patients with Autoimmune Disease: Results of a French Study.
37. Home versus hospital immunoglobulin treatment for autoimmune neuropathies: A cost minimization analysis.
38. July 2017 ENCALS statement on edaravone.
39. A study on the safety and efficacy of reveglucosidase alfa in patients with late-onset Pompe disease.
40. Bent spine syndrome as the initial symptom of late-onset Pompe disease.
41. European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10-year experience.
42. Short-TERM Neuromuscular Electrical Stimulation Training of the Tibialis Anterior Did Not Improve Strength and Motor Function in Facioscapulohumeral Muscular Dystrophy Patients.
43. Gender as a Modifying Factor Influencing Myotonic Dystrophy Type 1 Phenotype Severity and Mortality: A Nationwide Multiple Databases Cross-Sectional Observational Study.
44. Modeling Andersen's Syndrome in Human Induced Pluripotent Stem Cells.
45. Reply to the letter from Gazulla et al.
46. Deciphering spreading mechanisms in amyotrophic lateral sclerosis: clinical evidence and potential molecular processes.
47. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia.
48. Low penetrance in facioscapulohumeral muscular dystrophy type 1 with large pathological D4Z4 alleles: a cross-sectional multicenter study.
49. Evolution of Quality of Life, Mental Health, and Coping Strategies in Amyotrophic Lateral Sclerosis: A Pilot Study.
50. Motor and respiratory heterogeneity in Duchenne patients: Implication for clinical trials.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.